What is Hexarelin?

Hexarelin is a synthetic peptide from the GHRP (Growth Hormone Releasing Peptides) family, composed of 6 amino acids. In research models, it has been described as a potent agonist of the ghrelin receptor GHS-R1a, through which it stimulates the pituitary gland to release growth hormone (GH). In published data, Hexarelin is considered a peptide with a more stable structure and more pronounced activity compared to other representatives of the GHRP group. In research settings, it has been studied in relation to muscle growth, tissue regeneration, bone density, and cardioprotective mechanisms.

Observations on Hexarelin

Hexarelin is being investigated for its possible effects on:

Stimulation of growth hormone - associated with an increase in GH pulses and an elevation of IGF-1 secretion.

Increased muscle mass and strength - considered in connection with protein synthesis and anabolic processes.

Improved recovery - in research settings, it has been studied for its potential to shorten regeneration time after physical exertion.

Joint and bone health - investigated in relation to bone mineralization and the recovery of tendons and connective tissues.

Cardioprotective effects - in experimental models, a potential protective effect on the myocardium has been observed.

Anti-aging properties - in a scientific context, it has been considered for its possible influence on hormonal balance and catabolic processes.

An effect on deep sleep phases has also been described in research models.

Fat reduction - in experimental conditions, an influence on lipolysis and metabolic balance has been observed.

Administration and Dosage

In scientific literature, subcutaneous administration in the range of 100-300 μg daily has been described, usually divided into 1-2 applications within research protocols.

For 2 mg + 3 ml bacteriostatic water:

Concentration = 0.67 mg/ml → 0.15 ml = 100 μg

For 5 mg + 3 ml bacteriostatic water:

Concentration = 1.67 mg/ml → 0.1 ml = 167 μg

Example values for 2 mg:

0.15 ml = 100 μg

0.3 ml = 200 μg

0.45 ml = 300 μg

0.6 ml = 400 μg

Example values for 5 mg:

0.06 ml = 100 μg

0.12 ml = 200 μg

0.18 ml = 300 μg

0.24 ml = 400 μg

0.3 ml = 500 μg

Scientific Data

Hexarelin has been studied in preclinical and limited clinical models, where a dose-dependent effect on GH and IGF-1 secretion has been observed.

In endocrinological studies, Hexarelin has shown a significant impact on increasing GH and IGF-1, with no evidence of rapid exhaustion of receptor sensitivity within the models considered.

In cardiological experiments, protective effects have been described in models of ischemic heart injury, as well as a potential improvement in cardiac function.

In an orthopedic and regenerative context, data on accelerated recovery of bone, tendon, and connective tissue injuries have been considered.

In sports medicine, interest in Hexarelin is related to its anabolic potential, its influence on the GH/IGF-1 axis, and the possible shortening of recovery time after exertion.

Application in Sports

Hexarelin is prohibited by WADA for use in professional sports as it can:

• stimulate growth hormone secretion

• accelerate tissue recovery

• increase muscle mass and strength

• aid in fat reduction

Possible Side Effects

Reported adverse reactions in scientific literature are typically dose-dependent and include:

• redness, sensitivity, or pain at the injection site

• fatigue or drowsiness

• mild water retention

• increased appetite

• increased cortisol and prolactin levels at higher doses

Less frequently, in a research context, headaches, dizziness, or transient discomfort are described.

The information is collected and systematized from various scientific sources and studies. It serves educational purposes only and should not be used for diagnosis, treatment, or prevention of diseases.